Rabeprazole Hydroxy Compone CAS 675198-19-3 Puritas >99.5% (HPLC) Factory
Ruifu Chemical Supple Rabeprazole Sodium Intermedia
Rabeprazole Sodium CAS 117976-90-6
Rabeprazole Hydroxy Compone CAS 675198-19-3
Rabeprazole Chloride Compone CAS 153259-31-5
Nomen chemicum | [4-(3-Methyoxypropoxy)-3-Methyl-2-pyridinyl]methanolum hydrochloridum |
Synonyma | Rabeprazole Hydroxy Compound;(4-(3-Methoxypropoxy)-3-Methylpyridin-2-yl) methanolum hydrochloridum;4-(3-Methoxypropoxy)-3-Methylpyridine-2-Methanolum Hydrochloridum |
CAS Number | 675198-19-3 |
CATTUS Number | RF-PI1919 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C11H18ClNO3 |
M. Pondus | 247.72 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Lux Yellow Crystallina pulveris |
Asssay / Analysis Methodo | >99.5% (HPLC) |
Damnum in Siccatio | <0.50% |
Residere in Ignition | <0.20% |
Unam immunditiam | <0.50% |
Totalis immunditias | <0.50% |
Metalla gravis | <20ppm |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Rebeprazole Sodium (CAS: 117976-90-6) |
Rabeprazole Hydroxy Compone CAS 675198-19-3 Synthetica Route
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
[4-(3-Methyoxypropoxy)-3-Methyl-2-pyridinyl]methanolum hydrochloridum, Rabeprazole hydroxy compositum, (CAS: 675198-19-3) medium est Sodium Rebeprazole (CAS: 117976-90-6).Rabeprazole sodium azole cancri est protonia sentinae inhibitoris classis medicamenta sumens, nam ray Bella azole sodium salis forma, primum ab Eisai societas Iaponicorum primum feliciter evoluta est, nomen mercimoniae ad vim fluctuantem, munus protonii sentinae inhibitores est. acidum gastricum secretionem morborum stabilium arearum minuere, ita ut stomachum sanare et ulcera duodena et gulam regurgitationis stomachi morbum efficere.Maxime in curatione clinica morborum actis relatarum, ut ulcera gastrica et duodena lectio, ulceris peptici, refluxus gastroesophagi morbus, zhuoye syndrome etc.Natrium Rebeprazole velociorem impetum actionis habet comparatum cum omeprazole, sed temporis spatium breviorem.Rabeprazole est benzimidazolum substitutum, quod secretionem acidum gastricum vetat, ligando ad sentinam cellularum parietalium gastricae.Productum hoc impedit actionem triphosphatis adenosini, clavis enzyme in productione acidi gastrici.Secretionem inhibere potest acidum gastricum fundamentale et acidum gastricum excitando causatum.